SNX9

Across TCGA pan-cancer cohorts, SNX9 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SNX9 data layer compared with 27 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SNX9 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SNX9 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, ACC, and LUAD are the cancer types where SNX9 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.441	.025	20	view →
ACC	DFS	Median	All	0.089	0.666	.017	6	view →
LUAD	OS	Median	All	0.035	0.788	<.001	6	view →
SKCM	DFS	Median	IV	0.040	0.454	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SNX9–UCEC (DFS)

Open the UCEC breakdown →